Trelegy Ellipta Inhaler

Introduction to Trelegy Ellipta Inhaler

Trelegy Ellipta inhaler is a combination of three active drugs Fluticasone Furoate + Umeclidinium + Vilanterol. It is used to treat chronic obstructive pulmonary disease (COPD) symptoms such as wheezing, shortness of breath, coughing, and chest tightness in adults. It is also indicated to reduce the worsening of COPD in patients with a history of severe breathing symptoms. Fluticasone belongs to the group of drugs known as Corticosteroids. Umeclidinium is in a class of medication called anticholinergics. Vilanterol belongs to a group of drugs known as long-acting beta-agonists (LABAs). The combination of fluticasone, umeclidinium, and vilanterol eases breathing by relaxing and opening airways in the lungs.

Trelegy Ellipta Inhaler comes as a powder to inhale by mouth using an inhaler. This medicine should be used regularly as per your doctor’s advice. Do not use this if you are allergic to Fluticasone Furoate+Umeclidinium+Vilanterol or any of the other ingredients of this medicine. Inform your doctor if you have any heart, liver, or respiratory problems before starting the treatment. Report to the physician immediately if you have any symptoms of pneumonia or other respiratory disorders after using this medicine. This medicine is not recommended for children or adolescents below the age of 18 years.

The most frequent adverse effect of the Trelegy Ellipta inhaler is common cold. Along with this, you could also experience headaches, a cough, a clogged nose, a fungal infection of the mouth, and an infection of the nose. Inform your doctor if any of these adverse effects last longer than expected or develop worse.

Therapeutic Effects of Trelegy Ellipta Inhaler

The Trelegy Ellipta inhaler contains fluticasone furoate, a corticosteroid, umeclidinium, an anticholinergic, and vilanterol, a long-acting beta(2)-agonist. Fluticasone furoate inhibits pro-inflammatory signaling molecules by activating the steroid response element and prevents lung airway inflammation brought on by exposure to antigens. Umeclidinium inhibits certain receptors in the smooth muscles of the airway, leading to the dilation of bronchi and bronchioles. Vilanterol increases certain messenger levels in our body, which causes the bronchial smooth muscles to relax.

Interaction of Trelegy Ellipta Inhaler with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, or herbal products you take or have taken before the treatment. Certain medications containing CYP3A4 inhibitors may interact with the Trelegy Ellipta inhaler and cause undesirable side effects.

More Information about Trelegy Ellipta Inhaler

Keep this medicine out of sight and reach of children
Do not store above 30°C.
Store it away from heat, excessive moisture, and direct sunlight.
The inhaler has a window that shows the number of doses remaining. This tells you when you are getting low on medicine. The left half of the counter will turn red when there are less than 10 doses left to remind you to refill your prescription.

How to consume Trelegy Ellipta Inhaler

Your doctor will tell you how much medicine to use. Do not use more than directed. Use this medicine at the same time each day.

Trelegy Ellipta inhaler is a powder that is used with its own inhaler device. Keep the medicine in the foil tray until you are ready to use the inhaler.
Each time you open the cover of the inhaler and hear a click, the inhaler is ready to use. Do not close the cover until you have taken your dose. You will lose the dose if you open and close the cover without inhaling the medicine.
To inhale this medicine, breathe out fully and put the mouthpiece between your lips, and close your lips firmly around it. Take one long, steady, deep breath in through your mouth. Do not breathe in through your nose. Do not block the air vent with your fingers.
Remove the inhaler from your mouth and hold your breath for about 3 to 4 seconds, then breathe out slowly.
When you have finished inhaling, rinse your mouth out with water. Do not swallow the water.
You may clean the mouthpiece using a dry tissue, if needed, before closing the cover.

Safety Advices for Trelegy Ellipta Inhaler

Pregnancy

There is limited data regarding using Trelegy Ellipta inhaler in pregnant women to determine a drug-associated risk. If you are pregnant or think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Do not use this medicine if you are pregnant unless your doctor tells you to take it.

Breast Feeding

It is unknown whether Trelegy Ellipta inhaler are excreted in human milk. Ask your doctor for advice before taking this medicine. Do not use this medicine if you are breastfeeding or planning to breastfeed unless your doctor tells you to take it.

Lungs

Talk to your doctor before using the Trelegy Ellipta inhaler if you have liver problems.

Liver

Talk to your doctor before using the Trelegy Ellipta inhaler if you have liver problems.

Alcohol

It is not known whether it is safe to consume alcohol with the Trelegy Ellipta inhaler. Please consult your doctor.

Driving

It is unlikely that Trelegy Ellipta inhaler will affect your ability to drive or use machines. Please consult your doctor for more advice.

Side Effects of Trelegy Ellipta Inhaler

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Common:

Cough
Common cold and upper respiratory infections
Sore throat
Diarrhea
Headache
Back pain
Urinary tract infections
Influenza

Serious:

Increased heart rate
Increased blood sugar levels
Decreased potassium levels
Hypersensitivity reaction
Fungal infections
Decreased bone mineral density
Cataract, glaucoma
Severe respiratory problems

Reviews

There are no reviews yet.

Be the first to review “Trelegy Ellipta Inhaler”

Recently Viewed